GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have helped millions of people lose weight, manage diabetes, and improve heart health
*Product may contain benzyl alcohol as an inactive ingredient Contraindications for Benzyl Alcohol This preparation is not advised in patients who are sensitive to cobalt and/or vitamin B12
This can affect how you metabolize medications and utilize nutrients
One notable difference: semaglutide and tirzepatide have established prescribing information with FDA-approved dose ranges and flexibility for clinicians to hold patients at intermediate doses if tolerability is an issue
Related Weight Loss Research Compounds Semaglutide 20mg GLP-1 Receptor Agonist Tirzepatide 60mg Dual GLP-1/GIP Agonist Retatrutide 10mg Triple Agonist Research Peptide Retatrutide 20mg Triple Agonist Research Peptide AOD-9604 5mg Fat-Metabolism Research Fragment Scientific References Frias et al
Both modalities affect blood flow, and their interaction requires consideration to optimize peptide delivery while maximizing anti-inflammatory benefits